Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 2522 of 6351
-
MS drug holiday for Over-50s: safe or risky?
Disease control OngoingFurther controlled and randomized prospective studies in Multiple sclerosis, analyzing the potential impact of treatment discontinuation on disability progression, focal disease activity and quality of life are needed. The optimum patient age and duration of inactive SPMS before …
Phase 3 • Sponsor: Rennes University Hospital • Aim: Disease control
Last updated Jun 27, 2026 12:02 UTC
-
Ultrasound within 12 minutes may predict cardiac arrest outcomes
Knowledge-focused CompletedAssessment of prognostic performances of CCU in CRA Recovery (CRAR) has already been explored but 1) Only in intra-hospital medicine, 2) in very variable timings. ACE Research focuses on the extra-hospital window and predictive value of Early CCU (within 12 minutes of rescucitati…
Sponsor: Nantes University Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:08 UTC
-
Blueberry compound may boost cancer treatment in small trial
Disease control OngoingThis phase II trial studies how well megestrol acetate with or without pterostilbene works in treating patients with endometrial cancer undergoing hysterectomy. Drugs used in chemotherapy, such as megestrol acetate, work in different ways to stop the growth of tumor cells, either…
Phase 2 • Sponsor: City of Hope Medical Center • Aim: Disease control
Last updated Jun 27, 2026 13:01 UTC
-
Can group learning make biotherapy safer for arthritis patients?
Knowledge-focused CompletedThe hypothesis is that group interaction associated with individual interviews intensify the acquisition of safety skills compared to individual interviews alone in patients with CIR treated by subcutaneous biotherapies.
Sponsor: University Hospital, Clermont-Ferrand • Aim: Knowledge-focused
Last updated Aug 12, 2026 00:00 UTC
-
New test may expand olaparib benefits to more ovarian cancer patients
Knowledge-focused Stopped earlyPARP inhibitors are most effective in homologous recombinant (HR) deficient tumors. There are clear indications that besides BRCA1 or BRCA2 mutated EOC, there is an additional group of EOC having deficiencies in HR (i.e. BRCAness) that might benefit from treatment with PARP inhib…
Phase 2 • Sponsor: Leiden University Medical Center • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:06 UTC
-
Brain chip tracks seizures in real time – could it stop them?
Knowledge-focused OngoingResearchers are trying to determine if tracking seizure occurrence, seizure probability, behavioral state, cognition, and mood can be achieved using an implantable brain sensing and stimulation device (Medtronic RC+S Summit) coupled to an external, handheld, patient assistant dev…
Sponsor: Mayo Clinic • Aim: Knowledge-focused
Last updated Jun 27, 2026 11:02 UTC
-
Heart stent study shows promise for blocked arteries
Disease control CompletedThe aim of the study is to assess the safety and efficacy of the device to treat coronary de novo and restenotic lesions.
Sponsor: B. Braun Melsungen AG • Aim: Disease control
Last updated Jun 27, 2026 08:09 UTC
-
New hope: targeted pill may keep blood cancer in check after transplant
Disease control CompletedThis research study is studying a drug as a possible treatment for IDH1-mutant myeloid neoplasms. -The drug involved in this study is ivosidenib (AG-120)
Phase 1 • Sponsor: Massachusetts General Hospital • Aim: Disease control
Last updated Jun 27, 2026 07:56 UTC
-
New drug MT-2990 aims to ease endometriosis pain in small trial
Symptom relief CompletedThe purpose of this study is to assess the safety and efficacy of MT-2990 for treatment of moderate to severe endometriosis-related pain in women with surgically diagnosed endometriosis.
Phase 2 • Sponsor: Tanabe Pharma America, Inc. • Aim: Symptom relief
Last updated Jun 27, 2026 08:07 UTC
-
Can a cochlear implant bring back hearing after tumor removal?
Disease control OngoingThis study is a prospective, clinical study to determine if it is safe and effective to use a cochlear implant over time in individuals undergoing removal of a vestibular schwannoma (VS), benign tumor of the hearing and balance nerve or undergoing a labyrinthectomy for treatment …
Sponsor: Ohio State University • Aim: Disease control
Last updated Jun 27, 2026 12:33 UTC
-
New drug combo takes on tough pancreatic cancer
Disease control Recruiting nowThis is a phase 1 dose escalation trial of monotherapy misetionamide (also known as GP-2250) currently enrolling patients with platinum-resistant ovarian cancer (PROC) into Part 2 of the study. Part 1 of the study evaluating misetionamide in combination with gemcitabine in subjec…
Phase 1 • Sponsor: Persevere Therapeutics Inc. • Aim: Disease control
Last updated Jul 25, 2026 00:00 UTC
-
Breast cancer may harm egg quality before treatment even starts
Knowledge-focused OngoingAdvances in cancer diagnosis and treatments have improved the 5-year survival rate for patients over the last decade. Nevertheless, cancer treatments frequently alter patient's fertility, thus compromising their ability to conceive a child after remission. Consequently, it is rec…
Sponsor: University Hospital, Clermont-Ferrand • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:00 UTC
-
Kids' antipsychotic weight gain tracked for years in major safety study
Knowledge-focused CompletedMain LAP01 study: The purpose is to evaluate the long-term pathologic weight changes associated with multi-year risperidone or aripiprazole therapy in 3 - \<18-year-old children, who have varying durations of prior antipsychotic drug exposure from the start of study Month 0 (M0).…
Sponsor: Duke University • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:04 UTC
-
Laser showdown: which glaucoma protocol wins?
Disease control OngoingA randomized controlled trial to evaluate which treatment protocol in selective laser trabeculoplasty that is most optimal in terms of efficacy and safety.
Sponsor: Vastra Gotaland Region • Aim: Disease control
Last updated Aug 01, 2026 00:00 UTC
-
Can we predict dangerous side effects of cancer immunotherapy?
Knowledge-focused Recruiting nowImmune checkpoint inhibitors (ICIs) have transformed the treatment of solid tumors but are associated with immune-related adverse events (irAEs) that can affect virtually any organ system. While many irAEs are well recognized, neurological, neurocognitive, and psychiatric toxicit…
Sponsor: Shantou University Medical College • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:00 UTC
-
Could this be the end of yearly flu shots? early trial tests universal vaccine
Vaccine CompletedThe purpose of this study is to evaluate the immunogenicity and safety of inactivated subunit H5N1 influenza vaccine in individuals who have previously received live attenuated H2N2, H6N1, or H9N2 influenza vaccine, as well as in individuals who have never previously received H5N…
Phase 1 • Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) • Aim: Vaccine
Last updated Jun 27, 2026 07:51 UTC
-
Spinal stimulation without surgery shows promise for spasticity relief
Symptom relief Stopped earlySpinal cord injury is a devastating condition, causing substantial impairment of vital body functions caudal to the lesion. A major cause of disability stems from spasticity, a common secondary sequelae. Its various clinical manifestations include spasms, clonus, and resistance t…
Sponsor: Swiss Paraplegic Research, Nottwil • Aim: Symptom relief
Last updated Jun 27, 2026 08:00 UTC
-
Ultrasound zaps tremors in both hands: tiny trial shows promise
Disease control CompletedThe objective of this prospective, multi-site, single-arm, open-label study is to capture the safety and efficacy (outcome) of bilateral staged Exablate treatment in subjects with bilateral medication-refractory essential tremor (ET). The staged second procedure will be performed…
Sponsor: InSightec • Aim: Disease control
Last updated Jun 27, 2026 11:04 UTC
-
Can a blood test predict who will respond to ketamine for depression?
Knowledge-focused OngoingThis is a feasibility study and the goal of this project is to evaluate whether peak ACC GABA and glutamate, quantified as a CSF-corrected absolute concentration percent change from baseline, is associated with clinical remission, Montgomery Asberg Depression Rating Scale (MADRS)…
Early phase 1 • Sponsor: Mayo Clinic • Aim: Knowledge-focused
Last updated Jul 04, 2026 00:00 UTC
-
Low-Salt diet may shield veterans from heart failure
Prevention CompletedTens of thousands of Veterans have heart failure with preserved ejection fraction (HFpEF), and suffer poor quality of life, frequent hospitalizations, and high death rates. Older Veterans and those with high blood pressure, obesity, and the metabolic syndrome (abnormal cholestero…
Sponsor: VA Office of Research and Development • Aim: Prevention
Last updated Jun 26, 2026 16:45 UTC